MPM BioImpact’s investment team consists of professionals who have dedicated their careers to research and drug development, company creation, corporate strategy, and commercialization. Our Entrepreneur Partners provide deep domain expertise as investor-operators and work with our diverse group of scientists and professionals to develop therapies for diseases with high unmet needs. Collectively, we are a team of deeply experienced company creators who help transform scientific discoveries into breakthrough medicines for the patients that need them most.
Learn about our team of expertsInvesting
in the Future
of Medicine
We create and invest in biotech companies with innovative technologies that are developing life-saving drugs for patients. We invest in both private and public companies, providing a unique longitudinal view of drug development across the industry.
*
Companies created by MPM BioImpact include portfolio companies where MPM BioImpact was a co-founder or early lead investor from 2010 to today, representing the period that MPM BioImpact’s strategy has been focused on company creation.
We are Company Creators
Our team of scientists identifies innovative technologies and brings ideas to life by building companies from the ground up. We translate research into clinically meaningful drugs and potential cures.
i. The case study above is for illustrative purposes only and was not selected based on the performance of such investment. Rather, it is shown as a representative example of a company that MPM BioImpact created and built. This investment represents a portion of MPM BioImpact’s portfolio and is not intended to be representative of future investments.
iv. https://www.nytimes.com/2021/11/27/health/diabetes-cure-stem-cells.html